Jupiter Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Jupiter Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-87,543	Closed	-$1.38M	–	477
2024 Q1	$1.38M	Hold	87,543	–	–	0.01%	347
2023 Q4	$1.41M	Buy	87,543 +25,383	+41%	+$324K	0.01%	362
2023 Q3	$791K	Buy	62,160 +18,021	+41%	+$249K	0.01%	416
2023 Q2	$621K	Buy	+44,139	New	+$632K	0.01%	454

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Jupiter Asset Management's DCPH Position: Q2 2024 in Review

Jupiter Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 87,543 shares — an estimated $1.38M sold.

Jupiter Asset Management first reported a position in DCPH in Q2 2023 and held it in 4 quarters. The position peaked at $1.41M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Jupiter Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jupiter Asset Management sold 87,543 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.38M.
Jupiter Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
Jupiter Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.41M in Q4 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Jupiter Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.